Hunan Jiudian Pharmaceutical Co., Ltd. (SHE:300705)
China flag China · Delayed Price · Currency is CNY
10.64
-0.24 (-2.21%)
Sep 10, 2026, 12:44 PM CST

SHE:300705 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
2,8833,1082,9302,6912,3251,627
Other Revenue
2.912.791.151.020.890.82
2,8863,1112,9312,6932,3261,628
Revenue Growth
-6.20%6.15%8.85%15.75%42.92%66.40%
Cost of Revenue
922.7849.11790.88621.79522.52365.47
Gross Profit
1,9632,2622,1402,0711,8041,262
Selling, General & Admin
1,3591,4701,3311,4051,285878.31
Research & Development
170.77218.41245.97254.12201.26146.26
Other Operating Expenses
40.1928.725.1528.4725.8721.04
Operating Expenses
1,5691,7181,5981,6961,5251,051
Operating Income
393.93543.69541.62375.12278.84211.22
Interest Expense
-23.38-14.99-18.63-11.06-18.42-16.01
Interest & Investment Income
1.612.468.567.676.85.82
Currency Exchange Gain (Loss)
-0.61-0.06-0.26-0.42-0.27-0.14
Other Non Operating Income (Expenses)
-20.65-23.8-0.58-0.29-0.24-0.19
EBT Excluding Unusual Items
350.9507.31530.71371.02266.71200.7
Gain (Loss) on Sale of Investments
-2.23-0.96----
Gain (Loss) on Sale of Assets
-0.010.05-0.03-0.02
Asset Writedown
-3.47-4.22-1.92-1.46-1.3-1.9
Other Unusual Items
35.2324.1843.432.5724.8127.38
Pretax Income
380.42526.36572.19402.16290.22226.19
Income Tax Expense
46.756.3359.8233.920.5221.94
Earnings From Continuing Operations
333.72470.04512.38368.26269.7204.25
Minority Interest in Earnings
7.342.78----
Net Income
341.06472.82512.38368.26269.7204.25
Net Income to Common
341.06472.82512.38368.26269.7204.25
Net Income Growth
-34.37%-7.72%39.13%36.55%32.05%148.29%
Shares Outstanding (Basic)
445493488478460461
Shares Outstanding (Diluted)
446498493504460461
Shares Change
-11.34%1.02%-2.34%9.55%-0.15%0.13%
EPS (Basic)
0.770.961.050.770.590.44
EPS (Diluted)
0.760.951.040.730.590.44
EPS Growth
-25.98%-8.65%42.47%24.64%32.24%147.98%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
4.5-5.83348.54.37-144.3964.94
Free Cash Flow Per Share
0.01-0.010.710.01-0.310.14
Dividend Per Share
0.4000.4000.3130.2290.1690.133
Dividend Growth
27.81%27.81%36.49%36.00%26.67%507.76%
Gross Margin
68.03%72.70%73.01%76.91%77.54%77.55%
Operating Margin
13.65%17.48%18.48%13.93%11.99%12.98%
Profit Margin
11.82%15.20%17.48%13.68%11.59%12.55%
Free Cash Flow Margin
0.16%-0.19%11.89%0.16%-6.21%3.99%
EBITDA
544.87664.19636.49446.5338.49264.8
EBITDA Margin
18.88%21.35%21.72%16.58%14.55%16.27%
D&A For EBITDA
150.94120.594.8771.3759.6453.58
EBIT
393.93543.69541.62375.12278.84211.22
EBIT Margin
13.65%17.48%18.48%13.93%11.99%12.98%
Effective Tax Rate
12.28%10.70%10.45%8.43%7.07%9.70%
Revenue as Reported
2,8863,1112,9312,6932,3261,628
Advertising Expenses
-39.6479.6473.0177.4128.51